PHENYTOIN

PHENYTOIN was reported 20935 times

PHENYTOIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PURPLE GLOVE SYNDROME 65 0.4962
1 INSPIRATORY CAPACITY DECREASED 101 0.3646
2 URINE COPPER INCREASED 14 0.3500
3 NEW ONSET REFRACTORY STATUS EPILEPTICUS 31 0.2818
4 INTRA-ABDOMINAL PRESSURE INCREASED 35 0.2229
5 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 142 0.2185
6 ANGIOFIBROMA 14 0.1892
7 ANTICONVULSANT DRUG LEVEL ABNORMAL 33 0.1875
8 ANTICONVULSANT DRUG LEVEL INCREASED 298 0.1844
9 CEREBELLAR ATROPHY 144 0.1635
10 ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE 14 0.1538
11 POSTICTAL PARALYSIS 37 0.1529
12 ANTICONVULSANT DRUG LEVEL DECREASED 186 0.1316
13 NECROSIS ISCHAEMIC 54 0.1171
14 MULTIPLE-DRUG RESISTANCE 362 0.1166
15 CSF OLIGOCLONAL BAND PRESENT 15 0.1154
16 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 83 0.1102
17 HIPPOCAMPAL SCLEROSIS 13 0.1016
18 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 36 0.0947
19 BONE MARROW TRANSPLANT REJECTION 17 0.0773
20 PNEUMATOSIS 33 0.0740
21 STATUS EPILEPTICUS 812 0.0718
22 CONGENITAL APLASIA 22 0.0707
23 NYSTAGMUS 362 0.0681
24 DRUG-GENETIC INTERACTION 23 0.0644
25 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 34 0.0636
26 EPILEPTIC ENCEPHALOPATHY 14 0.0628
27 PROPOFOL INFUSION SYNDROME 43 0.0610
28 KIDNEY MALFORMATION 21 0.0597
29 GINGIVAL HYPERTROPHY 90 0.0593
30 CHOREOATHETOSIS 39 0.0574
31 PO2 INCREASED 29 0.0572
32 CRANIOFACIAL DEFORMITY 13 0.0558
33 RENAL ISCHAEMIA 30 0.0548
34 VITAMIN B6 DEFICIENCY 13 0.0528
35 NEURODEGENERATIVE DISORDER 29 0.0470
36 PCO2 INCREASED 32 0.0449
37 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 21 0.0449
38 ATAXIA 529 0.0445
39 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 142 0.0437
40 DRUG LEVEL FLUCTUATING 38 0.0428
41 PARTIAL SEIZURES 222 0.0424
42 PLEOCYTOSIS 24 0.0412
43 CEREBELLAR ATAXIA 39 0.0407
44 CYTOMEGALOVIRUS HEPATITIS 14 0.0395
45 SEIZURE CLUSTER 32 0.0386
46 DIABETES INSIPIDUS 90 0.0373
47 ATONIC SEIZURES 32 0.0373
48 FOETAL ANTICONVULSANT SYNDROME 44 0.0371
49 FOETAL MALFORMATION 40 0.0368
50 GINGIVAL HYPERPLASIA 22 0.0367
51 DRUG LEVEL CHANGED 23 0.0365
52 PYROGLUTAMIC ACIDOSIS 14 0.0353
53 ASTERIXIS 37 0.0348
54 STEVENS-JOHNSON SYNDROME 771 0.0346
55 MYOCLONIC EPILEPSY 52 0.0343
56 INTENTION TREMOR 19 0.0334
57 HYPERAMMONAEMIC ENCEPHALOPATHY 58 0.0333
58 DYSMETRIA 20 0.0331
59 BLOOD HOMOCYSTEINE INCREASED 14 0.0326
60 IDIOSYNCRATIC DRUG REACTION 31 0.0316
61 COMPLEX PARTIAL SEIZURES 35 0.0315
62 ACIDOSIS HYPERCHLORAEMIC 18 0.0303
63 ISCHAEMIC CEREBRAL INFARCTION 34 0.0293
64 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 14 0.0288
65 TONIC CONVULSION 40 0.0282
66 HYPERAMMONAEMIA 141 0.0282
67 ELECTROENCEPHALOGRAM ABNORMAL 89 0.0282
68 ANAL ATRESIA 15 0.0281
69 EXTENSOR PLANTAR RESPONSE 25 0.0271
70 PLAGIOCEPHALY 13 0.0261
71 LARYNGEAL STENOSIS 15 0.0260
72 GRAND MAL CONVULSION 239 0.0259
73 ENCEPHALOMALACIA 14 0.0249
74 THERAPEUTIC PRODUCT CROSS-REACTIVITY 22 0.0246
75 FOCAL DYSCOGNITIVE SEIZURES 28 0.0246
76 ENCEPHALITIS AUTOIMMUNE 32 0.0243
77 OVARIAN FAILURE 13 0.0243
78 MUCOSAL EROSION 22 0.0242
79 SIMPLE PARTIAL SEIZURES 19 0.0235
80 BRAIN HERNIATION 70 0.0234
81 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 603 0.0234
82 SJS-TEN OVERLAP 16 0.0228
83 DRUG LEVEL BELOW THERAPEUTIC 124 0.0225
84 TOXIC EPIDERMAL NECROLYSIS 341 0.0224
85 BLOOD PH DECREASED 38 0.0222
86 HYPOPLASTIC LEFT HEART SYNDROME 15 0.0221
87 CONVULSION 1262 0.0220
88 TRACHEO-OESOPHAGEAL FISTULA 14 0.0219
89 PERFORATION 17 0.0211
90 CEREBELLAR SYNDROME 46 0.0210
91 THERAPEUTIC AGENT TOXICITY 69 0.0207
92 BLOOD BICARBONATE DECREASED 39 0.0206
93 CLEFT LIP AND PALATE 23 0.0206
94 CROSS SENSITIVITY REACTION 20 0.0205
95 GAZE PALSY 35 0.0205
96 STUPOR 66 0.0205
97 CYTOKINE STORM 14 0.0204
98 PORPHYRIA ACUTE 29 0.0202
99 EXCESSIVE EYE BLINKING 29 0.0196
100 INHIBITORY DRUG INTERACTION 31 0.0196
101 DRUG LEVEL DECREASED 199 0.0195
102 VASOGENIC CEREBRAL OEDEMA 14 0.0194
103 BRADYCARDIA NEONATAL 24 0.0191
104 GENERALISED TONIC-CLONIC SEIZURE 315 0.0190
105 WHITE MATTER LESION 24 0.0190
106 PYLORIC STENOSIS 16 0.0189
107 SELECTIVE EATING DISORDER 17 0.0187
108 CHOREA 32 0.0186
109 CEREBRAL ATROPHY 74 0.0185
110 ALCOHOL WITHDRAWAL SYNDROME 16 0.0184
111 DRUG TOXICITY 244 0.0179
112 EPILEPSY 546 0.0178
113 MUCOSAL ULCERATION 18 0.0178
114 OROMANDIBULAR DYSTONIA 13 0.0178
115 SPINA BIFIDA 37 0.0177
116 SYNDACTYLY 14 0.0168
117 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 64 0.0167
118 CLEFT PALATE 32 0.0165
119 APALLIC SYNDROME 12 0.0165
120 INTESTINAL ISCHAEMIA 91 0.0165
121 HYPERREFLEXIA 57 0.0163
122 DYSMORPHISM 38 0.0161
123 POSTICTAL STATE 16 0.0154
124 OPHTHALMOPLEGIA 24 0.0152
125 CRYPTORCHISM 17 0.0151
126 DRUG LEVEL ABOVE THERAPEUTIC 69 0.0150
127 AURA 28 0.0150
128 MICROCEPHALY 19 0.0148
129 DRUG WITHDRAWAL CONVULSIONS 25 0.0140
130 SUPERINFECTION 21 0.0140
131 PETIT MAL EPILEPSY 69 0.0135
132 ACCIDENTAL DEATH 25 0.0134
133 BONE MARROW TRANSPLANT 25 0.0132
134 AREFLEXIA 35 0.0131
135 ALLODYNIA 15 0.0128
136 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 14 0.0127
137 RASH MORBILLIFORM 35 0.0126
138 ISCHAEMIC HEPATITIS 17 0.0124
139 SEIZURE 1431 0.0124
140 DRUG LEVEL INCREASED 205 0.0124
141 CENTRAL NERVOUS SYSTEM INFECTION 14 0.0122
142 LINEAR IGA DISEASE 20 0.0120
143 BRAIN OEDEMA 151 0.0119
144 DRUG RESISTANCE 306 0.0119
145 AUTISM 12 0.0118
146 RESPIRATORY DISORDER NEONATAL 19 0.0117
147 HYPERTROPHIC CARDIOMYOPATHY 18 0.0116
148 BRADYARRHYTHMIA 19 0.0116
149 SINUS ARREST 18 0.0115
150 HYPOREFLEXIA 22 0.0115
151 OBLITERATIVE BRONCHIOLITIS 15 0.0114
152 OXYGEN SATURATION ABNORMAL 32 0.0113
153 ENCEPHALITIS 78 0.0113
154 GINGIVAL DISORDER 43 0.0112
155 ACUTE GRAFT VERSUS HOST DISEASE 51 0.0111
156 MUTISM 16 0.0110
157 QUADRIPARESIS 18 0.0108
158 ERYTHEMA MULTIFORME 100 0.0107
159 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 44 0.0106
160 HIRSUTISM 14 0.0105
161 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 28 0.0105
162 RESPIRATORY ACIDOSIS 41 0.0104
163 PSYCHOMOTOR RETARDATION 29 0.0103
164 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 13 0.0102
165 HYPOVENTILATION 33 0.0101
166 HYPOSPADIAS 21 0.0101
167 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 75 0.0100
168 DRUG INTERACTION 1580 0.0099
169 COORDINATION ABNORMAL 138 0.0099
170 MUSCLE CONTRACTURE 20 0.0098
171 ANAEMIA MACROCYTIC 21 0.0098
172 CLONUS 26 0.0095
173 CHRONIC GRAFT VERSUS HOST DISEASE 34 0.0094
174 APGAR SCORE LOW 12 0.0093
175 ENCEPHALOPATHY 228 0.0093
176 HUMAN HERPESVIRUS 6 INFECTION 17 0.0090
177 COMA SCALE ABNORMAL 26 0.0090
178 PSEUDOMEMBRANOUS COLITIS 20 0.0089
179 POSTURE ABNORMAL 29 0.0089
180 VENOOCCLUSIVE LIVER DISEASE 43 0.0087
181 BLOOD ALBUMIN DECREASED 69 0.0087
182 LEFT VENTRICULAR HYPERTROPHY 37 0.0086
183 PUPILLARY REFLEX IMPAIRED 16 0.0086
184 SEDATION COMPLICATION 22 0.0086
185 WRONG PATIENT RECEIVED PRODUCT 25 0.0085
186 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 12 0.0085
187 TOXIC ENCEPHALOPATHY 43 0.0085
188 FOETAL DEATH 44 0.0085
189 GRAFT VERSUS HOST DISEASE 61 0.0085
190 METABOLIC ENCEPHALOPATHY 25 0.0083
191 AMMONIA INCREASED 42 0.0082
192 ATROPHY 16 0.0082
193 HYPOTHERMIA 83 0.0082
194 PARADOXICAL DRUG REACTION 30 0.0081
195 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 72 0.0081
196 TOXICITY TO VARIOUS AGENTS 1373 0.0081
197 APLASIA PURE RED CELL 28 0.0081
198 MYOCLONUS 97 0.0081
199 APRAXIA 12 0.0081
200 PUPIL FIXED 14 0.0081
201 MALABSORPTION 42 0.0080
202 HYPOTONIA 80 0.0080
203 DERMATITIS EXFOLIATIVE 40 0.0080
204 VENOOCCLUSIVE DISEASE 20 0.0080
205 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 62 0.0080
206 BLOOD LACTIC ACID INCREASED 42 0.0080
207 LACTOSE INTOLERANCE 20 0.0078
208 HEPATOSPLENOMEGALY 20 0.0078
209 PERSONALITY DISORDER 20 0.0076
210 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 20 0.0076
211 GENE MUTATION 15 0.0076
212 AUTONOMIC NERVOUS SYSTEM IMBALANCE 22 0.0075
213 MENTAL STATUS CHANGES 209 0.0075
214 ENDOTRACHEAL INTUBATION 21 0.0075
215 EOSINOPHILIA 130 0.0074
216 HISTIOCYTOSIS HAEMATOPHAGIC 22 0.0074
217 NOSOCOMIAL INFECTION 16 0.0073
218 HYPERSENSITIVITY VASCULITIS 19 0.0072
219 DYSARTHRIA 271 0.0072
220 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 68 0.0071
221 RASH MACULO-PAPULAR 158 0.0071
222 BRAIN OPERATION 16 0.0070
223 DIPLOPIA 182 0.0070
224 ACUTE MYELOID LEUKAEMIA RECURRENT 15 0.0070
225 CLUMSINESS 19 0.0070
226 VENTRICULAR DYSFUNCTION 18 0.0069
227 HAEMANGIOMA 16 0.0069
228 MULTIPLE DRUG OVERDOSE 34 0.0068
229 HYPERNATRAEMIA 34 0.0068
230 COMMUNICATION DISORDER 26 0.0068
231 NEUROTOXICITY 119 0.0068
232 AKINESIA 14 0.0068
233 DEPRESSED LEVEL OF CONSCIOUSNESS 267 0.0067
234 LEFT VENTRICULAR DYSFUNCTION 45 0.0067
235 CALCINOSIS 15 0.0067
236 ABDOMINAL WALL HAEMATOMA 13 0.0067
237 HEPATIC NECROSIS 25 0.0066
238 HYPERKINESIA 14 0.0066
239 TORTICOLLIS 14 0.0066
240 VOMITING PROJECTILE 19 0.0066
241 SEROTONIN SYNDROME 126 0.0066
242 ACUTE HEPATIC FAILURE 89 0.0065
243 ANTINUCLEAR ANTIBODY POSITIVE 21 0.0065
244 RENAL TUBULAR ACIDOSIS 14 0.0064
245 HYPERPARATHYROIDISM SECONDARY 16 0.0064
246 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 21 0.0064
247 DERMATITIS EXFOLIATIVE GENERALISED 22 0.0063
248 MULTIPLE DRUG OVERDOSE INTENTIONAL 20 0.0062
249 GAMMA-GLUTAMYLTRANSFERASE INCREASED 137 0.0062
250 MULTIPLE ORGAN DYSFUNCTION SYNDROME 175 0.0062
251 GASTROINTESTINAL NECROSIS 18 0.0062
252 MACULE 17 0.0061
253 NEUROLOGICAL DECOMPENSATION 14 0.0060
254 SEDATION 158 0.0060
255 WHITE BLOOD CELL DISORDER 16 0.0060
256 HEART DISEASE CONGENITAL 21 0.0059
257 HYPOALBUMINAEMIA 46 0.0059
258 HAEMODYNAMIC INSTABILITY 45 0.0059
259 MATERNAL DRUGS AFFECTING FOETUS 45 0.0059
260 ORAL INTAKE REDUCED 14 0.0058
261 METABOLIC ACIDOSIS 185 0.0058
262 HEPATITIS FULMINANT 17 0.0057
263 COAGULOPATHY 93 0.0056
264 UNRESPONSIVE TO STIMULI 142 0.0055
265 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 28 0.0055
266 LONG QT SYNDROME 13 0.0054
267 LEARNING DISORDER 13 0.0054
268 INTRACRANIAL PRESSURE INCREASED 30 0.0054
269 STARING 13 0.0054
270 FEELING OF DESPAIR 25 0.0054
271 HAEMODIALYSIS 45 0.0054
272 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 294 0.0054
273 CONJUNCTIVAL HYPERAEMIA 19 0.0053
274 EYE MOVEMENT DISORDER 36 0.0053
275 LEUKOCYTOSIS 95 0.0052
276 NEUROLEPTIC MALIGNANT SYNDROME 62 0.0052
277 RETINAL VEIN OCCLUSION 15 0.0052
278 GINGIVAL SWELLING 23 0.0052
279 PHARMACEUTICAL PRODUCT COMPLAINT 135 0.0052
280 BLOOD CALCIUM DECREASED 58 0.0052
281 ILEUS PARALYTIC 23 0.0051
282 MULTI-ORGAN FAILURE 89 0.0051
283 DRUG ERUPTION 91 0.0051
284 MENINGITIS ASEPTIC 23 0.0051
285 INCOHERENT 33 0.0051
286 BLOOD MAGNESIUM DECREASED 44 0.0051
287 POTENTIATING DRUG INTERACTION 17 0.0051
288 THROMBOTIC MICROANGIOPATHY 49 0.0050
289 ENTEROCOLITIS 29 0.0050
290 CANDIDIASIS 20 0.0050
291 STAPHYLOCOCCAL SEPSIS 24 0.0049
292 CACHEXIA 25 0.0049
293 HYPERTHERMIA 37 0.0048
294 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16 0.0048
295 DYSTONIA 93 0.0048
296 NEPHROGENIC ANAEMIA 22 0.0047
297 LIVER FUNCTION TEST ABNORMAL 138 0.0047
298 CYTOMEGALOVIRUS VIRAEMIA 21 0.0047
299 ALTERED STATE OF CONSCIOUSNESS 102 0.0047
300 COMA 224 0.0047
301 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 13 0.0047
302 PROTHROMBIN TIME PROLONGED 28 0.0047
303 DIFFICULTY IN WALKING 16 0.0046
304 ELECTRIC SHOCK SENSATION 13 0.0046
305 HEPATITIS ACUTE 30 0.0046
306 ISCHAEMIA 21 0.0046
307 ASPIRATION 50 0.0046
308 LEUKOENCEPHALOPATHY 17 0.0046
309 VENTRICULAR TACHYCARDIA 75 0.0045
310 IMMUNOSUPPRESSION 40 0.0045
311 BRAIN DEATH 14 0.0045
312 ANOREXIA 58 0.0045
313 CARDIOMEGALY 55 0.0045
314 VENTRICULAR FIBRILLATION 49 0.0044
315 HYDROCEPHALUS 24 0.0044
316 LOW BIRTH WEIGHT BABY 35 0.0044
317 PNEUMONIA ASPIRATION 109 0.0044
318 COMPLETED SUICIDE 359 0.0043
319 HEPATITIS 110 0.0043
320 CEREBRAL ISCHAEMIA 22 0.0043
321 ILEUS 53 0.0043
322 DELIRIUM 148 0.0043
323 BRAIN NEOPLASM 39 0.0042
324 PERIORBITAL OEDEMA 22 0.0042
325 COGNITIVE DISORDER 195 0.0042
326 DERMATITIS BULLOUS 30 0.0041
327 RASH VESICULAR 20 0.0041
328 TUBULOINTERSTITIAL NEPHRITIS 77 0.0041
329 INTERNATIONAL NORMALISED RATIO INCREASED 117 0.0041
330 EOSINOPHIL COUNT INCREASED 34 0.0041
331 RESPIRATORY DEPRESSION 50 0.0041
332 PULSELESS ELECTRICAL ACTIVITY 17 0.0041
333 BLOOD ALKALINE PHOSPHATASE INCREASED 100 0.0040
334 HYPERTRANSAMINASAEMIA 28 0.0040
335 ODYNOPHAGIA 24 0.0040
336 CARDIAC ARREST 330 0.0040
337 DYSKINESIA 162 0.0040
338 THROMBOTIC THROMBOCYTOPENIC PURPURA 14 0.0040
339 MAJOR DEPRESSION 29 0.0040
340 SKIN WARM 23 0.0039
341 ENTEROCOCCAL INFECTION 19 0.0039
342 POISONING 49 0.0039
343 BEHAVIOUR DISORDER 21 0.0039
344 PULMONARY HAEMORRHAGE 30 0.0038
345 VENTRICULAR ARRHYTHMIA 14 0.0038
346 HEPATIC FAILURE 115 0.0038
347 HYPOMAGNESAEMIA 53 0.0038
348 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 39 0.0038
349 VIITH NERVE PARALYSIS 13 0.0038
350 TRIGEMINAL NEURALGIA 15 0.0037
351 CYSTITIS HAEMORRHAGIC 15 0.0037
352 PEMPHIGOID 28 0.0037
353 ATRIOVENTRICULAR BLOCK FIRST DEGREE 16 0.0037
354 TRISMUS 19 0.0037
355 ACUTE RESPIRATORY DISTRESS SYNDROME 65 0.0037
356 PSYCHOTIC DISORDER 108 0.0037
357 HEPARIN-INDUCED THROMBOCYTOPENIA 18 0.0036
358 PETECHIAE 38 0.0036
359 HEMIPARESIS 61 0.0036
360 AGGRESSION 178 0.0036
361 FOETAL EXPOSURE DURING PREGNANCY 289 0.0036
362 LETHARGY 203 0.0035
363 PATENT DUCTUS ARTERIOSUS 14 0.0035
364 ALCOHOL USE 13 0.0035
365 ATELECTASIS 34 0.0035
366 HYPOGAMMAGLOBULINAEMIA 23 0.0035
367 RESPIRATORY RATE INCREASED 31 0.0035
368 BUNDLE BRANCH BLOCK RIGHT 16 0.0035
369 ORGAN FAILURE 14 0.0035
370 MATERNAL EXPOSURE TIMING UNSPECIFIED 13 0.0035
371 APLASTIC ANAEMIA 18 0.0034
372 HEPATIC ENCEPHALOPATHY 32 0.0034
373 SERUM FERRITIN INCREASED 18 0.0034
374 APHASIA 103 0.0034
375 LUNG INFILTRATION 30 0.0034
376 ASPARTATE AMINOTRANSFERASE INCREASED 180 0.0034
377 OLIGURIA 21 0.0034
378 DRUG-INDUCED LIVER INJURY 106 0.0034
379 BRADYCARDIA 179 0.0034
380 DISORIENTATION 133 0.0034
381 APNOEA 26 0.0033
382 NERVOUS SYSTEM DISORDER 104 0.0033
383 RASH GENERALISED 86 0.0033
384 FACE OEDEMA 56 0.0033
385 LYMPHADENOPATHY 117 0.0033
386 SUBDURAL HAEMATOMA 47 0.0033
387 NO THERAPEUTIC RESPONSE 40 0.0033
388 RESPIRATORY ARREST 90 0.0033
389 CONFUSIONAL STATE 526 0.0033
390 HEPATIC FUNCTION ABNORMAL 121 0.0032
391 ALANINE AMINOTRANSFERASE INCREASED 198 0.0032
392 RESPIRATORY DISTRESS 89 0.0032
393 RHABDOMYOLYSIS 133 0.0032
394 ELECTROCARDIOGRAM ABNORMAL 25 0.0032
395 HYPONATRAEMIA 179 0.0032
396 HYPERURICAEMIA 13 0.0032
397 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 16 0.0032
398 ACIDOSIS 24 0.0031
399 MENTAL IMPAIRMENT 76 0.0031
400 SKIN LACERATION 34 0.0031
401 ELECTROCARDIOGRAM QT PROLONGED 112 0.0031
402 COLITIS ISCHAEMIC 21 0.0031
403 BLOOD LACTATE DEHYDROGENASE INCREASED 49 0.0031
404 CAESAREAN SECTION 36 0.0031
405 BRAIN INJURY 31 0.0031
406 AUTISM SPECTRUM DISORDER 17 0.0031
407 AKATHISIA 42 0.0031
408 HAEMORRHAGE INTRACRANIAL 46 0.0031
409 BALANCE DISORDER 265 0.0031
410 SUPRAVENTRICULAR TACHYCARDIA 29 0.0030
411 HALLUCINATION, AUDITORY 48 0.0030
412 ELECTROLYTE IMBALANCE 35 0.0030
413 SHOCK 69 0.0030
414 GANGRENE 18 0.0030
415 CONGENITAL ANOMALY 23 0.0030
416 GINGIVITIS 16 0.0030
417 MEDICATION ERROR 164 0.0029
418 MUSCLE TWITCHING 68 0.0029
419 AGITATION 215 0.0029
420 MUSCLE RIGIDITY 35 0.0029
421 TRANSAMINASES INCREASED 65 0.0029
422 SEPSIS 324 0.0029
423 SOMNAMBULISM 19 0.0029
424 RESPIRATORY FAILURE 211 0.0029
425 DEVELOPMENTAL DELAY 26 0.0029
426 SEPTIC SHOCK 125 0.0029
427 LACERATION 27 0.0029
428 CATATONIA 15 0.0029
429 AGRANULOCYTOSIS 53 0.0028
430 INTESTINAL PERFORATION 32 0.0028
431 SPEECH DISORDER 148 0.0028
432 HEPATITIS CHOLESTATIC 17 0.0028
433 TREATMENT FAILURE 233 0.0028
434 HEPATIC ENZYME ABNORMAL 14 0.0028
435 HYDRONEPHROSIS 21 0.0028
436 PSEUDOMONAS INFECTION 24 0.0028
437 KLEBSIELLA INFECTION 14 0.0028
438 SOMNOLENCE 553 0.0027
439 INCONTINENCE 29 0.0027
440 REBOUND EFFECT 31 0.0027
441 PULSE ABSENT 13 0.0027
442 FEMORAL NECK FRACTURE 14 0.0027
443 MYDRIASIS 35 0.0027
444 TACHYPNOEA 37 0.0027
445 EPSTEIN-BARR VIRUS INFECTION 17 0.0027
446 PURPURA 24 0.0027
447 ABNORMAL BEHAVIOUR 107 0.0027
448 THROMBOCYTOPENIA 300 0.0027
449 HEPATOTOXICITY 59 0.0026
450 MOTOR DYSFUNCTION 27 0.0026
451 CARDIOGENIC SHOCK 38 0.0026
452 HEPATOMEGALY 26 0.0026
453 BLOOD CREATINE PHOSPHOKINASE INCREASED 76 0.0026
454 HYPOTENSION 529 0.0026
455 GRANULOCYTOPENIA 15 0.0026
456 END STAGE RENAL DISEASE 48 0.0026
457 FOETAL GROWTH RESTRICTION 16 0.0026
458 THERAPY NON-RESPONDER 118 0.0026
459 VENTRICULAR SEPTAL DEFECT 15 0.0026
460 HYPERTONIA 15 0.0026
461 ABDOMINAL TENDERNESS 13 0.0026
462 VISUAL DISTURBANCE 15 0.0026
463 HEPATIC CIRRHOSIS 49 0.0026
464 HERPES VIRUS INFECTION 15 0.0026
465 METABOLIC DISORDER 15 0.0026
466 PREMATURE DELIVERY 41 0.0026
467 PRODUCT SUBSTITUTION ISSUE 148 0.0026
468 CEREBRAL DISORDER 19 0.0026
469 SUBARACHNOID HAEMORRHAGE 26 0.0026
470 MENINGITIS 17 0.0025
471 INTENTIONAL OVERDOSE 163 0.0025
472 ENDOCARDITIS 13 0.0025
473 DRUG SCREEN POSITIVE 20 0.0025
474 NECROSIS 14 0.0025
475 LOSS OF CONSCIOUSNESS 321 0.0025
476 MALNUTRITION 28 0.0025
477 HEARING IMPAIRED 15 0.0025
478 RASH PUSTULAR 18 0.0025
479 CYTOMEGALOVIRUS INFECTION 41 0.0025
480 CARDIO-RESPIRATORY ARREST 103 0.0025
481 VITAMIN D DEFICIENCY 24 0.0025
482 NEUROLOGICAL SYMPTOM 14 0.0024
483 ABORTION INDUCED 23 0.0024
484 HYPOTHYROIDISM 78 0.0024
485 ABNORMAL FAECES 20 0.0024
486 ESCHERICHIA INFECTION 20 0.0024
487 TACHYCARDIA 216 0.0024
488 TREATMENT NONCOMPLIANCE 133 0.0024
489 MUCOSAL INFLAMMATION 63 0.0024
490 URINE OUTPUT DECREASED 21 0.0024
491 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
492 SPINAL OSTEOARTHRITIS 21 0.0024
493 NEUTROPENIC SEPSIS 17 0.0024
494 SINUS BRADYCARDIA 23 0.0024
495 HYPOCALCAEMIA 45 0.0024
496 MATERNAL EXPOSURE DURING PREGNANCY 211 0.0024
497 PARKINSONISM 23 0.0024
498 PREMATURE BABY 71 0.0024
499 CLOSTRIDIUM DIFFICILE COLITIS 25 0.0024
500 RENAL FAILURE ACUTE 100 0.0024
501 MYOCARDITIS 27 0.0024
502 CARDIOTOXICITY 21 0.0024
503 DISSEMINATED INTRAVASCULAR COAGULATION 33 0.0023
504 ENTERITIS 15 0.0023
505 PHOTOPHOBIA 44 0.0023
506 ATRIOVENTRICULAR BLOCK 18 0.0023
507 DISEASE RECURRENCE 110 0.0023
508 SALIVARY HYPERSECRETION 23 0.0023
509 TORSADE DE POINTES 18 0.0023
510 UROSEPSIS 21 0.0023
511 MIOSIS 18 0.0022
512 FACIAL PAIN 20 0.0022
513 BODY TEMPERATURE INCREASED 45 0.0022
514 HYPOKINESIA 32 0.0022
515 LIVER INJURY 54 0.0022
516 APATHY 32 0.0022
517 LYMPHOEDEMA 15 0.0022
518 PSYCHOMOTOR HYPERACTIVITY 36 0.0022
519 HYPOPHOSPHATAEMIA 16 0.0022
520 HEMIPLEGIA 18 0.0022
521 CYANOSIS 34 0.0022
522 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
523 CONJUNCTIVITIS 40 0.0022
524 FEELING DRUNK 16 0.0022
525 BLOOD UREA INCREASED 36 0.0021
526 REFUSAL OF TREATMENT BY PATIENT 14 0.0021
527 BRADYPHRENIA 14 0.0021
528 DEEP VEIN THROMBOSIS 138 0.0021
529 HEAD INJURY 67 0.0021
530 THERAPY PARTIAL RESPONDER 33 0.0021
531 SOPOR 28 0.0021
532 ABASIA 52 0.0021
533 DRUG INEFFECTIVE 2773 0.0021
534 PARANOIA 36 0.0021
535 MOVEMENT DISORDER 67 0.0021
536 DECUBITUS ULCER 17 0.0021
537 HALLUCINATION, VISUAL 44 0.0021
538 JOINT DISLOCATION 22 0.0021
539 CARDIAC MURMUR 18 0.0021
540 LEUKOPENIA 104 0.0021
541 VISUAL FIELD DEFECT 15 0.0021
542 BLOOD SODIUM DECREASED 39 0.0021
543 DERMATITIS ALLERGIC 26 0.0021
544 DELUSION 32 0.0021
545 CIRCULATORY COLLAPSE 35 0.0021
546 HAEMORRHAGIC STROKE 16 0.0020
547 ORAL DISORDER 15 0.0020
548 OSTEOPENIA 31 0.0020
549 GAIT DISTURBANCE 390 0.0020
550 DROOLING 14 0.0020
551 PRESCRIBED OVERDOSE 39 0.0020
552 POISONING DELIBERATE 19 0.0020
553 HYPERGLYCAEMIA 73 0.0020
554 BLISTER 112 0.0020
555 FACIAL PARALYSIS 17 0.0020
556 PYREXIA 687 0.0020
557 LUPUS-LIKE SYNDROME 18 0.0020
558 CHOLESTASIS 38 0.0020
559 HAND FRACTURE 14 0.0020
560 NEPHROPATHY TOXIC 22 0.0020
561 HYPERAESTHESIA 16 0.0019
562 HYPERCALCAEMIA 24 0.0019
563 IMPAIRED DRIVING ABILITY 22 0.0019
564 EXPOSURE DURING PREGNANCY 120 0.0019
565 ACUTE RESPIRATORY FAILURE 37 0.0019
566 CONDITION AGGRAVATED 584 0.0019
567 HYPERSOMNIA 55 0.0019
568 URINARY RETENTION 64 0.0019
569 HYPERKALAEMIA 67 0.0019
570 AFFECTIVE DISORDER 15 0.0019
571 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 135 0.0019
572 BLOOD BILIRUBIN INCREASED 51 0.0019
573 TOXIC SKIN ERUPTION 19 0.0019
574 ABSCESS 30 0.0019
575 BLOOD DISORDER 15 0.0019
576 TREMOR 309 0.0019
577 FALL 618 0.0019
578 BACTERAEMIA 22 0.0019
579 MOUTH ULCERATION 39 0.0018
580 ACTIVITIES OF DAILY LIVING IMPAIRED 36 0.0018
581 INTENTIONAL DRUG MISUSE 38 0.0018
582 TOOTH FRACTURE 20 0.0018
583 OVERDOSE 390 0.0018
584 ASCITES 53 0.0018
585 DYSPHAGIA 169 0.0018
586 TRICUSPID VALVE INCOMPETENCE 14 0.0018
587 PHARYNGEAL OEDEMA 27 0.0018
588 POLYNEUROPATHY 21 0.0018
589 RESTLESSNESS 64 0.0017
590 OESOPHAGITIS 19 0.0017
591 HYPERBILIRUBINAEMIA 18 0.0017
592 MYOPATHY 15 0.0017
593 RASH ERYTHEMATOUS 83 0.0017
594 ARRHYTHMIA 82 0.0017
595 HEPATIC ENZYME INCREASED 118 0.0017
596 BODY TEMPERATURE DECREASED 17 0.0017
597 AMNESIA 112 0.0017
598 EYELID OEDEMA 20 0.0017
599 CYTOPENIA 21 0.0017
600 HAEMATOCRIT DECREASED 34 0.0017
601 DYSSTASIA 50 0.0017
602 FEAR 46 0.0017
603 RENAL FAILURE 225 0.0017
604 RENAL FAILURE CHRONIC 13 0.0017
605 PARALYSIS 24 0.0017
606 CEREBRAL HAEMORRHAGE 60 0.0017
607 HAEMOLYTIC ANAEMIA 15 0.0017
608 CENTRAL NERVOUS SYSTEM LESION 23 0.0017
609 HYPERLIPIDAEMIA 20 0.0017
610 GOUT 30 0.0017
611 MYOSITIS 15 0.0017
612 LIVER DISORDER 74 0.0017
613 BLOOD POTASSIUM INCREASED 27 0.0017
614 JAUNDICE 44 0.0016
615 URINARY INCONTINENCE 48 0.0016
616 WHITE BLOOD CELL COUNT INCREASED 62 0.0016
617 GENERALISED OEDEMA 20 0.0016
618 GINGIVAL BLEEDING 22 0.0016
619 THINKING ABNORMAL 30 0.0016
620 LIP SWELLING 53 0.0016
621 HYPOXIA 56 0.0016
622 ACUTE KIDNEY INJURY 243 0.0016
623 SUICIDE ATTEMPT 95 0.0016
624 SKIN REACTION 22 0.0016
625 CEREBRAL INFARCTION 38 0.0016
626 ATRIAL SEPTAL DEFECT 13 0.0016
627 IRRITABILITY 92 0.0015
628 PERIPHERAL COLDNESS 21 0.0015
629 RENAL TUBULAR NECROSIS 15 0.0015
630 DRUG EXPOSURE DURING PREGNANCY 52 0.0015
631 BEDRIDDEN 20 0.0015
632 PULMONARY CONGESTION 20 0.0015
633 SUDDEN DEATH 16 0.0015
634 ACCIDENTAL OVERDOSE 55 0.0015
635 NEUTROPENIA 204 0.0015
636 BLOOD POTASSIUM DECREASED 45 0.0015
637 VERTIGO 91 0.0015
638 PANCYTOPENIA 83 0.0015
639 OSTEOPOROSIS 61 0.0015
640 CHRONIC KIDNEY DISEASE 112 0.0015
641 MUSCLE SPASTICITY 18 0.0015
642 HALLUCINATION 110 0.0015
643 ROAD TRAFFIC ACCIDENT 61 0.0015
644 MEMORY IMPAIRMENT 199 0.0014
645 FEBRILE NEUTROPENIA 96 0.0014
646 RED BLOOD CELL SEDIMENTATION RATE INCREASED 16 0.0014
647 VENTRICULAR EXTRASYSTOLES 15 0.0014
648 BLINDNESS 58 0.0014
649 MITRAL VALVE INCOMPETENCE 16 0.0014
650 POST PROCEDURAL COMPLICATION 27 0.0014
651 RENAL IMPAIRMENT 118 0.0014
652 SCAR 24 0.0014
653 PERSONALITY CHANGE 13 0.0014
654 HEPATIC STEATOSIS 26 0.0014
655 SKIN LESION 38 0.0014
656 VISUAL ACUITY REDUCED 46 0.0014
657 PULMONARY OEDEMA 62 0.0014
658 ANGIOEDEMA 61 0.0014
659 SPINAL PAIN 16 0.0014
660 HYPOKALAEMIA 63 0.0014
661 HYPOGLYCAEMIA 66 0.0014
662 PALLOR 37 0.0014
663 LYMPHOCYTE COUNT DECREASED 24 0.0014
664 DRUG PRESCRIBING ERROR 26 0.0014
665 PREGNANCY 27 0.0013
666 HAEMATURIA 46 0.0013
667 MUSCLE ATROPHY 17 0.0013
668 METASTASES TO BONE 22 0.0013
669 DIALYSIS 19 0.0013
670 SINUS TACHYCARDIA 19 0.0013
671 SKIN INFECTION 15 0.0013
672 PANCREATITIS ACUTE 30 0.0013
673 PLEURAL EFFUSION 81 0.0013
674 PNEUMOTHORAX 21 0.0013
675 UPPER LIMB FRACTURE 26 0.0013
676 NEOPLASM 15 0.0013
677 TOOTH DISORDER 29 0.0013
678 OFF LABEL USE 1140 0.0013
679 BIPOLAR DISORDER 14 0.0013
680 STOMATITIS 78 0.0013
681 DRUG INTOLERANCE 124 0.0013
682 SPLENOMEGALY 15 0.0013
683 BONE MARROW FAILURE 26 0.0013
684 NEUTROPHIL COUNT INCREASED 13 0.0013
685 EATING DISORDER 27 0.0013
686 GASTRIC ULCER 24 0.0013
687 HYPERTENSIVE CRISIS 14 0.0013
688 BLOOD CREATININE INCREASED 82 0.0013
689 PRURITUS GENERALISED 27 0.0012
690 EYE DISORDER 41 0.0012
691 DRUG DISPENSING ERROR 19 0.0012
692 INTENTIONAL SELF-INJURY 25 0.0012
693 C-REACTIVE PROTEIN INCREASED 45 0.0012
694 RASH PRURITIC 67 0.0012
695 MYOCARDIAL ISCHAEMIA 14 0.0012
696 NEUROPATHY PERIPHERAL 117 0.0012
697 DISTURBANCE IN ATTENTION 66 0.0012
698 JOINT INJURY 26 0.0012
699 DIZZINESS 607 0.0012
700 ORAL CANDIDIASIS 16 0.0012
701 TOOTH LOSS 25 0.0012
702 RASH MACULAR 42 0.0012
703 DEPRESSED MOOD 63 0.0012
704 PRODUCT USE IN UNAPPROVED INDICATION 295 0.0012
705 HIP FRACTURE 38 0.0012
706 SUICIDAL IDEATION 108 0.0012
707 RASH 513 0.0012
708 INFECTION 170 0.0012
709 TARDIVE DYSKINESIA 33 0.0012
710 DEVICE RELATED INFECTION 18 0.0012
711 EMOTIONAL DISORDER 36 0.0012
712 URINARY TRACT INFECTION 198 0.0012
713 OSTEOMYELITIS 21 0.0012
714 HEPATITIS C 14 0.0012
715 CRYING 42 0.0012
716 SWOLLEN TONGUE 36 0.0012
717 PNEUMONIA 371 0.0011
718 SMALL INTESTINAL OBSTRUCTION 14 0.0011
719 HYPOPHAGIA 29 0.0011
720 DRUG EFFECT DECREASED 61 0.0011
721 VISION BLURRED 155 0.0011
722 VOMITING 530 0.0011
723 MENTAL DISORDER 49 0.0011
724 OEDEMA 61 0.0011
725 IMPAIRED WORK ABILITY 24 0.0011
726 ISCHAEMIC STROKE 20 0.0011
727 GENERAL PHYSICAL HEALTH DETERIORATION 129 0.0011
728 LACTIC ACIDOSIS 36 0.0011
729 DEMENTIA 31 0.0011
730 CHROMATURIA 25 0.0011
731 SLEEP APNOEA SYNDROME 21 0.0011
732 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
733 TRANSIENT ISCHAEMIC ATTACK 37 0.0011
734 CHOLECYSTITIS 13 0.0011
735 CARDIOMYOPATHY 16 0.0011
736 THERAPEUTIC RESPONSE DECREASED 65 0.0011
737 NERVOUSNESS 56 0.0011
738 LIVER FUNCTION TEST INCREASED 23 0.0011
739 CARPAL TUNNEL SYNDROME 15 0.0011
740 ANGER 36 0.0011
741 HEPATOCELLULAR INJURY 15 0.0011
742 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
743 ADVERSE REACTION 14 0.0011
744 ACUTE MYOCARDIAL INFARCTION 31 0.0011
745 TOOTHACHE 19 0.0010
746 MOBILITY DECREASED 75 0.0010
747 ABDOMINAL DISTENSION 108 0.0010
748 ANKLE FRACTURE 16 0.0010
749 OXYGEN SATURATION DECREASED 58 0.0010
750 PLATELET COUNT DECREASED 110 0.0010
751 MUSCULAR WEAKNESS 117 0.0010
752 GASTROINTESTINAL HAEMORRHAGE 86 0.0010
753 DISEASE PROGRESSION 121 0.0010
754 PANCREATITIS 54 0.0010
755 DRUG ABUSE 85 0.0010
756 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
757 METASTASES TO CENTRAL NERVOUS SYSTEM 13 0.0010
758 CANDIDA INFECTION 17 0.0010
759 OBESITY 16 0.0010
760 STAPHYLOCOCCAL INFECTION 33 0.0010
761 GASTROENTERITIS VIRAL 18 0.0010
762 HAEMATEMESIS 25 0.0010
763 ANAEMIA 187 0.0010
764 RIB FRACTURE 20 0.0010
765 MUSCULOSKELETAL STIFFNESS 84 0.0010
766 BRAIN FOG 15 0.0010
767 HAEMOGLOBIN DECREASED 98 0.0010
768 PERICARDIAL EFFUSION 22 0.0010
769 UPPER GASTROINTESTINAL HAEMORRHAGE 16 0.0010
770 MOOD SWINGS 30 0.0009
771 SKIN DISORDER 31 0.0009
772 DEPRESSION 211 0.0009
773 CORONARY ARTERY DISEASE 28 0.0009
774 ECONOMIC PROBLEM 14 0.0009
775 ABORTION SPONTANEOUS 37 0.0009
776 PRODUCT AVAILABILITY ISSUE 21 0.0009
777 SWELLING FACE 60 0.0009
778 LYMPHOPENIA 13 0.0009
779 PERITONITIS 19 0.0009
780 CELLULITIS 46 0.0009
781 DERMATITIS 19 0.0009
782 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
783 ASTHENIA 336 0.0009
784 ATRIAL FIBRILLATION 87 0.0009
785 HAEMATOMA 23 0.0009
786 POOR QUALITY SLEEP 19 0.0009
787 INJURY 62 0.0009
788 PNEUMONITIS 24 0.0009
789 BLOOD CHOLESTEROL INCREASED 41 0.0009
790 BONE DISORDER 16 0.0009
791 DIABETIC KETOACIDOSIS 21 0.0009
792 GASTRITIS 23 0.0009
793 FUNGAL INFECTION 29 0.0009
794 OEDEMA PERIPHERAL 106 0.0009
795 BACK DISORDER 14 0.0009
796 BLOOD PRESSURE DECREASED 57 0.0009
797 PARAESTHESIA 133 0.0008
798 MOOD ALTERED 23 0.0008
799 RENAL INJURY 25 0.0008
800 HYPERSENSITIVITY 156 0.0008
801 HEART RATE INCREASED 83 0.0008
802 TINNITUS 38 0.0008
803 PRODUCT PRESCRIBING ISSUE 18 0.0008
804 CEREBROVASCULAR ACCIDENT 139 0.0008
805 PULMONARY EMBOLISM 77 0.0008
806 WITHDRAWAL SYNDROME 34 0.0008
807 GAIT INABILITY 27 0.0008
808 HYPOAESTHESIA 120 0.0008
809 UPPER RESPIRATORY TRACT INFECTION 37 0.0008
810 DRUG EFFECT INCOMPLETE 29 0.0008
811 CHOLELITHIASIS 26 0.0008
812 EAR INFECTION 21 0.0008
813 DIABETES MELLITUS 60 0.0008
814 INTERSTITIAL LUNG DISEASE 38 0.0008
815 PAIN IN JAW 22 0.0008
816 HERNIA 15 0.0008
817 HEART RATE DECREASED 27 0.0008
818 RESPIRATORY DISORDER 23 0.0008
819 CONTUSION 74 0.0008
820 PULMONARY HYPERTENSION 16 0.0008
821 ANHEDONIA 20 0.0008
822 DYSURIA 28 0.0008
823 CONTRAINDICATED PRODUCT ADMINISTERED 23 0.0008
824 ORAL PAIN 17 0.0008
825 SPINAL FRACTURE 15 0.0007
826 LOCAL SWELLING 13 0.0007
827 HYPERTENSION 157 0.0007
828 SKIN DISCOLOURATION 34 0.0007
829 RED BLOOD CELL COUNT DECREASED 21 0.0007
830 HEAD DISCOMFORT 13 0.0007
831 THROMBOSIS 59 0.0007
832 MELAENA 16 0.0007
833 UNEVALUABLE EVENT 55 0.0007
834 EXTRAPYRAMIDAL DISORDER 18 0.0007
835 SKIN EXFOLIATION 61 0.0007
836 CARDIAC FAILURE 58 0.0007
837 HAEMORRHAGE 75 0.0007
838 NEUTROPHIL COUNT DECREASED 29 0.0007
839 VISUAL IMPAIRMENT 88 0.0007
840 EPISTAXIS 53 0.0007
841 FLUSHING 72 0.0007
842 ERYTHEMA 145 0.0007
843 DEHYDRATION 94 0.0007
844 PRESYNCOPE 17 0.0007
845 PRODUCTIVE COUGH 33 0.0007
846 SYNCOPE 69 0.0007
847 PRODUCT DISPENSING ERROR 15 0.0007
848 CLOSTRIDIUM DIFFICILE INFECTION 15 0.0007
849 HEADACHE 426 0.0007
850 LOWER LIMB FRACTURE 13 0.0007
851 HYPERHIDROSIS 87 0.0007
852 CARDIAC FAILURE CONGESTIVE 54 0.0007
853 ABDOMINAL PAIN 156 0.0007
854 ANAPHYLACTIC REACTION 37 0.0007
855 DECREASED APPETITE 155 0.0007
856 INSOMNIA 177 0.0007
857 CONSTIPATION 143 0.0007
858 NAUSEA 517 0.0007
859 LUNG DISORDER 32 0.0007
860 ANXIETY 185 0.0006
861 WHITE BLOOD CELL COUNT DECREASED 70 0.0006
862 VAGINAL HAEMORRHAGE 28 0.0006
863 WEIGHT DECREASED 179 0.0006
864 COLITIS 24 0.0006
865 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 33 0.0006
866 PRODUCT USE ISSUE 118 0.0006
867 RASH PAPULAR 14 0.0006
868 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 30 0.0006
869 ERECTILE DYSFUNCTION 16 0.0006
870 INFLAMMATION 32 0.0006
871 LOWER RESPIRATORY TRACT INFECTION 28 0.0006
872 INCORRECT ROUTE OF DRUG ADMINISTRATION 22 0.0006
873 DRUG WITHDRAWAL SYNDROME 54 0.0006
874 FEELING ABNORMAL 146 0.0006
875 BLOOD PRESSURE ABNORMAL 12 0.0006
876 URTICARIA 101 0.0006
877 WEIGHT INCREASED 134 0.0006
878 INTENTIONAL PRODUCT MISUSE 52 0.0006
879 CARDIOVASCULAR DISORDER 15 0.0006
880 BLOOD GLUCOSE DECREASED 28 0.0006
881 FEMUR FRACTURE 18 0.0006
882 THERAPEUTIC PRODUCT EFFECT DECREASED 26 0.0006
883 FATIGUE 445 0.0006
884 GASTROINTESTINAL DISORDER 51 0.0006
885 BLOOD PRESSURE INCREASED 87 0.0006
886 SLEEP DISORDER 40 0.0006
887 SWELLING 53 0.0006
888 MIGRAINE 54 0.0006
889 MALAISE 246 0.0006
890 INTESTINAL OBSTRUCTION 21 0.0006
891 DYSPNOEA 310 0.0005
892 NEOPLASM PROGRESSION 19 0.0005
893 PRODUCT PRESCRIBING ERROR 13 0.0005
894 ADVERSE DRUG REACTION 49 0.0005
895 CARDIAC DISORDER 51 0.0005
896 NEPHROLITHIASIS 25 0.0005
897 PRURITUS 204 0.0005
898 MUSCLE SPASMS 97 0.0005
899 EYE PAIN 29 0.0005
900 EYE SWELLING 19 0.0005
901 SYSTEMIC LUPUS ERYTHEMATOSUS 18 0.0005
902 THERAPY CESSATION 26 0.0005
903 DYSPNOEA EXERTIONAL 19 0.0005
904 MULTIPLE SCLEROSIS 24 0.0005
905 HAEMOPTYSIS 14 0.0005
906 DIARRHOEA 321 0.0005
907 CHEST PAIN 92 0.0005
908 ARTHRITIS 39 0.0005
909 RECTAL HAEMORRHAGE 21 0.0005
910 DRUG ADMINISTRATION ERROR 15 0.0005
911 PAIN IN EXTREMITY 142 0.0005
912 INCORRECT DOSE ADMINISTERED 110 0.0005
913 LIMB INJURY 13 0.0005
914 MUSCULOSKELETAL PAIN 25 0.0005
915 INFLUENZA LIKE ILLNESS 39 0.0005
916 RENAL DISORDER 22 0.0005
917 HERPES ZOSTER 27 0.0005
918 INTENTIONAL PRODUCT USE ISSUE 41 0.0005
919 MULTIPLE SCLEROSIS RELAPSE 32 0.0005
920 NO ADVERSE EVENT 84 0.0005
921 WHEEZING 27 0.0005
922 VIRAL INFECTION 15 0.0005
923 MYOCARDIAL INFARCTION 78 0.0004
924 ILL-DEFINED DISORDER 27 0.0004
925 DRY MOUTH 36 0.0004
926 LABORATORY TEST ABNORMAL 13 0.0004
927 INFLUENZA 49 0.0004
928 BACK PAIN 101 0.0004
929 DEATH 374 0.0004
930 LACRIMATION INCREASED 13 0.0004
931 BURNING SENSATION 30 0.0004
932 IMPAIRED HEALING 14 0.0004
933 GASTROOESOPHAGEAL REFLUX DISEASE 34 0.0004
934 PERIPHERAL SWELLING 65 0.0004
935 DRY EYE 21 0.0004
936 COUGH 117 0.0004
937 PAIN 256 0.0004
938 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 14 0.0004
939 EMOTIONAL DISTRESS 50 0.0004
940 PANIC ATTACK 15 0.0004
941 COVID-19 72 0.0004
942 MALIGNANT NEOPLASM PROGRESSION 42 0.0004
943 CYSTITIS 13 0.0004
944 BRONCHITIS 30 0.0004
945 ADVERSE EVENT 37 0.0004
946 OSTEOARTHRITIS 17 0.0004
947 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 28 0.0004
948 CHILLS 46 0.0004
949 HAEMATOCHEZIA 21 0.0004
950 NASOPHARYNGITIS 70 0.0004
951 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
952 NECK PAIN 21 0.0004
953 NIGHTMARE 13 0.0004
954 CATARACT 22 0.0004
955 POLLAKIURIA 15 0.0004
956 MYALGIA 61 0.0004
957 SURGERY 21 0.0004
958 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13 0.0004
959 HYPOACUSIS 15 0.0003
960 ABDOMINAL PAIN UPPER 70 0.0003
961 DYSPEPSIA 33 0.0003
962 DYSPHONIA 19 0.0003
963 ARTHROPATHY 18 0.0003
964 FEELING HOT 19 0.0003
965 THERAPY INTERRUPTED 22 0.0003
966 ECZEMA 16 0.0003
967 ILLNESS 31 0.0003
968 PRODUCT DOSE OMISSION 19 0.0003
969 ARTHRALGIA 120 0.0003
970 PRODUCT QUALITY ISSUE 39 0.0003
971 INFUSION RELATED REACTION 19 0.0003
972 DRY SKIN 38 0.0003
973 DRUG DOSE OMISSION 47 0.0003
974 BLOOD GLUCOSE INCREASED 53 0.0003
975 OROPHARYNGEAL PAIN 26 0.0003
976 HOSPITALISATION 43 0.0003
977 JOINT SWELLING 33 0.0003
978 PALPITATIONS 32 0.0003
979 ALOPECIA 53 0.0003
980 ABDOMINAL DISCOMFORT 45 0.0003
981 BONE PAIN 15 0.0003
982 UNDERDOSE 18 0.0002
983 CHEST DISCOMFORT 25 0.0002
984 PRODUCT DOSE OMISSION ISSUE 69 0.0002
985 FLATULENCE 13 0.0002
986 NASAL CONGESTION 13 0.0002
987 DYSGEUSIA 16 0.0002
988 NEOPLASM MALIGNANT 14 0.0002
989 SINUSITIS 21 0.0002
990 DRUG DEPENDENCE 31 0.0002
991 ASTHMA 21 0.0002
992 RHEUMATOID ARTHRITIS 20 0.0002
993 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 27 0.0001
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 29 0.0001
995 PSORIASIS 17 0.0001
996 INJECTION SITE PAIN 21 0.0001